Nguyen H, Luong N, Peil J, Tong Y, Mitchell D, Fishel M
Biomacromolecules. 2025; 26(2):1098-1110.
PMID: 39841789
PMC: 11817685.
DOI: 10.1021/acs.biomac.4c01441.
Connaughton M, Dabagh M
Biomed Eng Online. 2024; 23(1):88.
PMID: 39210409
PMC: 11363431.
DOI: 10.1186/s12938-024-01278-0.
Nakamura H, Watanabe M, Takada K, Sato T, Hikage F, Umetsu A
Biomedicines. 2024; 12(5).
PMID: 38790973
PMC: 11118094.
DOI: 10.3390/biomedicines12051011.
Connaughton M, Dabagh M
IEEE J Transl Eng Health Med. 2024; 12:413-434.
PMID: 38765886
PMC: 11100865.
DOI: 10.1109/JTEHM.2024.3388561.
Wehrli M, Guinn S, Birocchi F, Kuo A, Sun Y, Larson R
Clin Cancer Res. 2024; 30(9):1859-1877.
PMID: 38393682
PMC: 11062832.
DOI: 10.1158/1078-0432.CCR-23-3841.
Free-Standing Hierarchically Porous Silica Nanoparticle Superstructures: Bridging the Nano- to Microscale for Tailorable Delivery of Small and Large Therapeutics.
Palvai S, Kpeglo D, Newham G, Peyman S, Evans S, Ong Z
ACS Appl Mater Interfaces. 2024; 16(5):5568-5581.
PMID: 38270578
PMC: 10859928.
DOI: 10.1021/acsami.3c16463.
Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC.
Bidan N, Dunsmore G, Ugrinic M, Bied M, Moreira M, Delomenie C
Drug Deliv Transl Res. 2023; 14(8):2085-2099.
PMID: 38062286
DOI: 10.1007/s13346-023-01479-5.
Assessing the Layer-by-Layer Assembly of Cellulose Nanofibrils and Polyelectrolytes in Pancreatic Tumor Spheroid Formation.
Abbasi Aval N, Lahchaichi E, Tudoran O, Fayazbakhsh F, Heuchel R, Lohr M
Biomedicines. 2023; 11(11).
PMID: 38002061
PMC: 10669291.
DOI: 10.3390/biomedicines11113061.
AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
Ingle K, LaComb J, Graves L, Baines A, Bialkowska A
PLoS One. 2023; 18(11):e0294065.
PMID: 37943821
PMC: 10635512.
DOI: 10.1371/journal.pone.0294065.
The challenge of making the right choice: patient avatars in the era of cancer immunotherapies.
Kayser C, Brauer A, Susanne S, Wandmacher A
Front Immunol. 2023; 14:1237565.
PMID: 37638045
PMC: 10449253.
DOI: 10.3389/fimmu.2023.1237565.
Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma.
Lintern N, Smith A, Jayne D, Khaled Y
Cancers (Basel). 2023; 15(16).
PMID: 37627163
PMC: 10453210.
DOI: 10.3390/cancers15164135.
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T, Xie Y, Hou X, Bai W, Li X, Liu Z
J Exp Clin Cancer Res. 2023; 42(1):111.
PMID: 37143164
PMC: 10157938.
DOI: 10.1186/s13046-023-02671-8.
Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids.
Dinter J, Friedrich R, Yang H, Pilarsky C, Mangge H, Pottler M
Materials (Basel). 2023; 16(7).
PMID: 37049199
PMC: 10096321.
DOI: 10.3390/ma16072906.
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment.
Tanaka H, Nakazawa T, Enomoto A, Masamune A, Kano M
Cancers (Basel). 2023; 15(3).
PMID: 36765684
PMC: 9913712.
DOI: 10.3390/cancers15030724.
Modeling Obesity-Driven Pancreatic Carcinogenesis-A Review of Current In Vivo and In Vitro Models of Obesity and Pancreatic Carcinogenesis.
Kfoury S, Michl P, Roth L
Cells. 2022; 11(19).
PMID: 36231132
PMC: 9563584.
DOI: 10.3390/cells11193170.
Laminarin Attenuates ROS-Mediated Cell Migration and Invasiveness through Mitochondrial Dysfunction in Pancreatic Cancer Cells.
Lee W, Song G, Bae H
Antioxidants (Basel). 2022; 11(9).
PMID: 36139787
PMC: 9495390.
DOI: 10.3390/antiox11091714.
A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
Li A, Ye B, Lin F, Wang Y, Miao X, Jiang Y
Precis Clin Med. 2022; 5(2):pbac010.
PMID: 35694712
PMC: 9172649.
DOI: 10.1093/pcmedi/pbac010.